Welcome to LookChem.com Sign In|Join Free

CAS

  • or
7-Methylxanthine, also known as an oxopurine, is a member of the xanthine class. It is an intermediate metabolite in the synthesis of caffeine and is characterized by its grey solid appearance. 7-METHYLXANTHINE can be synthesized through the reaction between 4-amino-1-methylimidazole-5-carboxamide and diethyl carbonate. As a metabolite of theophylline and caffeine, 7-methylxanthine plays a significant role in the biochemistry of these well-known stimulants.

552-62-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 552-62-5 Structure
  • Basic information

    1. Product Name: 7-METHYLXANTHINE
    2. Synonyms: 3,7-dihydro-7-methyl-1h-purine-6-dione;7-methyl-xanthin;3,7-dihydro-7-methyl-1H-purine-2,6-dione;7-Methylxantine;7-METHYLXANTHINE XANTHINE DERIVATIVE;2,6-Dihydroxy-7-methylpurine, Heteroxanthine;7-methyl-3H-purine-2,6-dione;NSC 7861
    3. CAS NO:552-62-5
    4. Molecular Formula: C6H6N4O2
    5. Molecular Weight: 166.14
    6. EINECS: 209-019-0
    7. Product Categories: Pyridines, Pyrimidines, Purines and Pteredines;Bases & Related Reagents;Heterocycles;Metabolites & Impurities;Nucleotides;Heterocycles, Metabolites & Impurities, Nucleotides, Bases & Related Reagents
    8. Mol File: 552-62-5.mol
  • Chemical Properties

    1. Melting Point: ≥300 °C
    2. Boiling Point: °Cat760mmHg
    3. Flash Point: °C
    4. Appearance: /
    5. Density: 1.83g/cm3
    6. Refractive Index: 1.827
    7. Storage Temp.: 2-8°C
    8. Solubility: DMSO (Slightly, Heated), Methanol (Slightly, Heated)
    9. PKA: pK1:8.33;pK2:ca;pK3:13 (25°C)
    10. Water Solubility: Soluble in dimethyl sulfoxide. Insoluble in water.
    11. BRN: 171027
    12. CAS DataBase Reference: 7-METHYLXANTHINE(CAS DataBase Reference)
    13. NIST Chemistry Reference: 7-METHYLXANTHINE(552-62-5)
    14. EPA Substance Registry System: 7-METHYLXANTHINE(552-62-5)
  • Safety Data

    1. Hazard Codes: T+
    2. Statements: 26/27/28
    3. Safety Statements: 22-24/25
    4. WGK Germany: 3
    5. RTECS: ZD8925000
    6. F: 10
    7. HazardClass: N/A
    8. PackingGroup: N/A
    9. Hazardous Substances Data: 552-62-5(Hazardous Substances Data)

552-62-5 Usage

Uses

Used in Pharmaceutical Industry:
7-Methylxanthine is used as a building block for the synthesis of tricyclic imidazo[2,1-i]purinone derivatives, which have potential as adenosine receptor antagonists. These antagonists can be utilized in the development of medications targeting various conditions, such as asthma, chronic obstructive pulmonary disease (COPD), and other disorders where adenosine receptor modulation is beneficial.
Used in Metabolism Studies:
As a metabolite of theophylline and caffeine, 7-methylxanthine is essential in understanding the metabolic pathways and effects of these stimulants on the human body. This knowledge can be applied to optimize the use of these compounds in medical treatments and to study their potential side effects and interactions with other substances.
Used in Chemical Research:
The chemical properties of 7-methylxanthine, such as its grey solid appearance and its classification as an oxopurine, make it a valuable subject for research in the field of chemistry. Understanding its properties and reactivity can contribute to the development of new synthetic methods, potential applications, and insights into the broader class of xanthines.

Check Digit Verification of cas no

The CAS Registry Mumber 552-62-5 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,5 and 2 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 552-62:
(5*5)+(4*5)+(3*2)+(2*6)+(1*2)=65
65 % 10 = 5
So 552-62-5 is a valid CAS Registry Number.
InChI:InChI=1/C6H6N4O2/c1-10-2-7-4-3(10)5(11)9-6(12)8-4/h2H,1H3,(H2,8,9,11,12)

552-62-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H29190)  7-Methylxanthine, 98%   

  • 552-62-5

  • 50mg

  • 626.0CNY

  • Detail
  • Alfa Aesar

  • (H29190)  7-Methylxanthine, 98%   

  • 552-62-5

  • 250mg

  • 1930.0CNY

  • Detail
  • Alfa Aesar

  • (H29190)  7-Methylxanthine, 98%   

  • 552-62-5

  • 1g

  • 5480.0CNY

  • Detail
  • Aldrich

  • (69723)  7-Methylxanthine  ≥98.0% (HPLC)

  • 552-62-5

  • 69723-250MG

  • 2,260.44CNY

  • Detail
  • Aldrich

  • (69723)  7-Methylxanthine  ≥98.0% (HPLC)

  • 552-62-5

  • 69723-1G

  • 5,545.80CNY

  • Detail

552-62-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 7-methylxanthine

1.2 Other means of identification

Product number -
Other names 7-Methylxanthine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:552-62-5 SDS

552-62-5Synthetic route

2,6-dibenzyloxy-7-methylpurine
1021187-27-8

2,6-dibenzyloxy-7-methylpurine

7-methylxanthine
552-62-5

7-methylxanthine

Conditions
ConditionsYield
With sodium hydroxide In dimethyl sulfoxide at 100℃; for 1.5h;92%
2,6-dibenzylthio-7-methylpurine
1021187-29-0

2,6-dibenzylthio-7-methylpurine

7-methylxanthine
552-62-5

7-methylxanthine

Conditions
ConditionsYield
With sodium hydroxide In dimethyl sulfoxide at 100℃; for 1.5h;90%
3-benzyl-7-methyl-1H-purine-2,6(3H,7H)-dione
64995-73-9

3-benzyl-7-methyl-1H-purine-2,6(3H,7H)-dione

7-methylxanthine
552-62-5

7-methylxanthine

Conditions
ConditionsYield
With aluminium trichloride In toluene at 70℃; for 1h;75%
4-amino-5-cyano-1-methyl-1H-imidazole
40637-80-7

4-amino-5-cyano-1-methyl-1H-imidazole

urethane
51-79-6

urethane

7-methylxanthine
552-62-5

7-methylxanthine

Conditions
ConditionsYield
at 180℃;
2,6-dichloro-7-methylpurine
2273-93-0

2,6-dichloro-7-methylpurine

7-methylxanthine
552-62-5

7-methylxanthine

Conditions
ConditionsYield
With hydrogenchloride at 120 - 125℃;
Multi-step reaction with 2 steps
1: 80 percent / methanol / 2 h / 100 °C
2: 18percent aq. HCl / 1.5 h / Heating
View Scheme
With hydrogenchloride at 120 - 125℃;
2,6-dimethoxy-7-methyl-purine
97184-74-2

2,6-dimethoxy-7-methyl-purine

7-methylxanthine
552-62-5

7-methylxanthine

Conditions
ConditionsYield
With hydrogenchloride for 1.5h; Heating; Yield given;
7-methyl xanthosine

7-methyl xanthosine

7-methylxanthine
552-62-5

7-methylxanthine

Conditions
ConditionsYield
With N-methyl nucleoside hydrolase; Tricine-NaOH buffer at 37℃; for 1h; enzymatic hydrolysis, effect of pH, temperature,metal ions and reagents on enzyme activity;
7,9-dimethylxanthinium iodide
86180-29-2

7,9-dimethylxanthinium iodide

A

theobromine /
83-67-0

theobromine /

B

7-methylxanthine
552-62-5

7-methylxanthine

Conditions
ConditionsYield
at 230℃; for 0.75h; Title compound not separated from byproducts;
7,9-dimethylxanthinium hydrogensulfate

7,9-dimethylxanthinium hydrogensulfate

A

theobromine /
83-67-0

theobromine /

B

7-methylxanthine
552-62-5

7-methylxanthine

Conditions
ConditionsYield
at 250℃; for 0.25h; Title compound not separated from byproducts;
7-methyl-2-hydroxy-6-methoxypurine
85982-53-2

7-methyl-2-hydroxy-6-methoxypurine

7-methylxanthine
552-62-5

7-methylxanthine

Conditions
ConditionsYield
With acid
2-methoxy-6-ethoxy-7-methylpurine
97184-78-6

2-methoxy-6-ethoxy-7-methylpurine

7-methylxanthine
552-62-5

7-methylxanthine

Conditions
ConditionsYield
With hydrogenchloride for 1.5h; Heating; Yield given;
7-methyl-2-chloro-6-ethoxy-purine

7-methyl-2-chloro-6-ethoxy-purine

7-methylxanthine
552-62-5

7-methylxanthine

Conditions
ConditionsYield
With hydrogenchloride at 100℃;
7-methyl-2-chloro-adenine

7-methyl-2-chloro-adenine

7-methylxanthine
552-62-5

7-methylxanthine

Conditions
ConditionsYield
With hydrogenchloride at 120 - 125℃;
7-methyl-2-chloro-hypoxanthine

7-methyl-2-chloro-hypoxanthine

7-methylxanthine
552-62-5

7-methylxanthine

Conditions
ConditionsYield
With hydrogenchloride at 120 - 125℃;
7-methyl-guanine

7-methyl-guanine

7-methylxanthine
552-62-5

7-methylxanthine

Conditions
ConditionsYield
With cis-nitrous acid
8-chloro-heteroxanthine

8-chloro-heteroxanthine

7-methylxanthine
552-62-5

7-methylxanthine

Conditions
ConditionsYield
With phosphonium iodide; hydrogen iodide
Diethyl carbonate
105-58-8

Diethyl carbonate

1-methyl-4-amino-imidazole-carboxylic acid-(5)-amide

1-methyl-4-amino-imidazole-carboxylic acid-(5)-amide

7-methylxanthine
552-62-5

7-methylxanthine

Conditions
ConditionsYield
at 160 - 170℃;
6-amino-1-benzyl-5-(methylamino)uracil
72816-88-7

6-amino-1-benzyl-5-(methylamino)uracil

7-methylxanthine
552-62-5

7-methylxanthine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 91 percent / 12 h / Heating
2: 75 percent / AlCl3 / toluene / 1 h / 70 °C
View Scheme
2-chloro-6-ethoxy-7-methylpurine
97202-78-3

2-chloro-6-ethoxy-7-methylpurine

7-methylxanthine
552-62-5

7-methylxanthine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 77 percent / methanol / 2 h / 120 °C
2: 18percent aq. HCl / 1.5 h / Heating
View Scheme
6-chloro-7-methyl-7H-purine
5440-17-5

6-chloro-7-methyl-7H-purine

7-methylxanthine
552-62-5

7-methylxanthine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: methanol
2: 49 percent / 30 percent H2O2 / trifluoroacetic acid / 288 h / Ambient temperature
3: 56 percent / methanol / Irradiation
4: acid
View Scheme
6-methoxy-7-methyl-7H-purine
38917-24-7

6-methoxy-7-methyl-7H-purine

7-methylxanthine
552-62-5

7-methylxanthine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 49 percent / 30 percent H2O2 / trifluoroacetic acid / 288 h / Ambient temperature
2: 56 percent / methanol / Irradiation
3: acid
View Scheme
6-methoxy-7-methylpurine 3-oxide
85982-51-0

6-methoxy-7-methylpurine 3-oxide

7-methylxanthine
552-62-5

7-methylxanthine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 56 percent / methanol / Irradiation
2: acid
View Scheme
theobromine /
83-67-0

theobromine /

7-methylxanthine
552-62-5

7-methylxanthine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: phosphorus oxychloride / 140 °C
2: hydrochloric acid / 120 - 125 °C
View Scheme
7-methylguanine hydrochloride

7-methylguanine hydrochloride

7-methylxanthine
552-62-5

7-methylxanthine

Conditions
ConditionsYield
With acetic acid; sodium nitrite
7-methylxanthine
552-62-5

7-methylxanthine

(2-trimethylethylsilylethoxy)methyl chloride
76513-69-4

(2-trimethylethylsilylethoxy)methyl chloride

7-methyl-3-(2-trimethylsilyl)ethoxymethylxanthine
246264-71-1

7-methyl-3-(2-trimethylsilyl)ethoxymethylxanthine

Conditions
ConditionsYield
69%
7-methylxanthine
552-62-5

7-methylxanthine

1,5-dichloropentane
628-76-2

1,5-dichloropentane

1,3-Bis(ω-chloropentyl)-7-methyl-xanthine
125663-73-2

1,3-Bis(ω-chloropentyl)-7-methyl-xanthine

Conditions
ConditionsYield
With sodium hydroxide In N,N-dimethyl-formamide at 85 - 105℃;68%
7-methylxanthine
552-62-5

7-methylxanthine

7-methyl-8 nitroxanthine

7-methyl-8 nitroxanthine

Conditions
ConditionsYield
With nitronium tetrafluoborate; acetic acid at 120℃; for 1h;38%
2-bromomethylfuran
4437-18-7

2-bromomethylfuran

aqueous sodium chloride

aqueous sodium chloride

7-methylxanthine
552-62-5

7-methylxanthine

3-(furan-2-ylmethyl)-7-methylxanthine
301328-85-8

3-(furan-2-ylmethyl)-7-methylxanthine

Conditions
ConditionsYield
With sodium sulfate In water; dimethyl sulfoxide; ethyl acetate14%
With sodium sulfate In water; dimethyl sulfoxide; ethyl acetate
allyl iodid
556-56-9

allyl iodid

7-methylxanthine
552-62-5

7-methylxanthine

3-allyl-7-methyl-3,7-dihydro-purine-2,6-dione
64995-72-8

3-allyl-7-methyl-3,7-dihydro-purine-2,6-dione

Conditions
ConditionsYield
With potassium hydroxide
7-methylxanthine
552-62-5

7-methylxanthine

7-methyl-2-oxo-6-thioxo-1,2,3,6-tetrahydropurine
38695-88-4

7-methyl-2-oxo-6-thioxo-1,2,3,6-tetrahydropurine

Conditions
ConditionsYield
With pyridine; tetraphosphorus decasulfide
With pyridine; tetraphosphorus decasulfide for 8h; Heating;
7-methylxanthine
552-62-5

7-methylxanthine

2,6-dichloro-7-methylpurine
2273-93-0

2,6-dichloro-7-methylpurine

Conditions
ConditionsYield
With phosphorus pentachloride; trichlorophosphate
formaldehyd
50-00-0

formaldehyd

7-methylxanthine
552-62-5

7-methylxanthine

1,3-Bis-hydroxymethyl-7-methyl-3,7-dihydro-purine-2,6-dione

1,3-Bis-hydroxymethyl-7-methyl-3,7-dihydro-purine-2,6-dione

Conditions
ConditionsYield
With triethylamine In water Ambient temperature;
7-methylxanthine
552-62-5

7-methylxanthine

7-Methyl-3,7-dihydro-purine-2,6-dione

7-Methyl-3,7-dihydro-purine-2,6-dione

Conditions
ConditionsYield
With azide radical In water at 25℃; Rate constant; various pH;
7-methylxanthine
552-62-5

7-methylxanthine

methyl iodide
74-88-4

methyl iodide

aqueous alcoholic KOH-solution

aqueous alcoholic KOH-solution

3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione
58-08-2

3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione

7-methylxanthine
552-62-5

7-methylxanthine

sulfuric acid
7664-93-9

sulfuric acid

potassium permanganate

potassium permanganate

A

ammonia
7664-41-7

ammonia

B

methylamine
74-89-5

methylamine

552-62-5Relevant articles and documents

Xanthines studied via femtosecond fluorescence spectroscopy

Changenet-Barret, Pascale,Kovács, Lajos,Markovitsi, Dimitra,Gustavsson, Thomas

, (2016)

Xanthines represent a wide class of compounds closely related to the DNA bases adenine and guanine. Ubiquitous in the human body, they are capable of replacing natural bases in double helices and give rise to four-stranded structures. Although the use of their fluorescence for analytical purposes was proposed, their fluorescence properties have not been properly characterized so far. The present paper reports the first fluorescence study of xanthine solutions relying on femtosecond spectroscopy. Initially, we focus on 3-methylxanthine, showing that this compound exhibits non-exponential fluorescence decays with no significant dependence on the emission wavelength. The fluorescence quantum yield (3 × 10-4) and average decay time (0.9 ps) are slightly larger than those found for the DNA bases. Subsequently, we compare the dynamical fluorescence properties of seven mono-, di- and tri-methylated derivatives. Both the fluorescence decays and fluorescence anisotropies vary only weakly with the site and the degree of methylation. These findings are in line with theoretical predictions suggesting the involvement of several conical intersections in the relaxation of the lowest singlet excited state.

APPLICATIONS OF N6-SUBSTITUTED ADENOSINE DERIVATIVE AND N6-SUBSTITUTED ADENINE DERIVATIVE TO CALMING, HYPNOSES, CONVULSION RESISTANCE, EPILEPTIC RESISTANCE, PARKINSON DISEASE RESISTANCE, AND DEMENTIA PREVENTION AND TREATMENT

-

Paragraph 0190, (2018/10/27)

PROBLEM TO BE SOLVED: To prepare analgesics, hypnotic agents, anticonvulsant agents, antiepileptics, antiparkinson drugs, dementia prophylactics, and health care food. SOLUTION: The present invention relates to an N6-substituted adenosine derivative and an N6-substituted adenine derivative selected from the group consisting of specific compounds. The present invention also relates to a pharmaceutical composition at least comprising a therapeutically effective amount of the compounds and a pharmaceutically acceptable carrier. The invention further relates to the compounds used in preparation of analgesics, hypnotic agents, anticonvulsant agents, antiepileptics, antiparkinson drugs, dementia prophylactics, and health care food. COPYRIGHT: (C)2016,JPO&INPIT

N6-SUBSTITUTED ADENOSINE DERIVATIVES AND N6-SUBSTITUTED ADENINE DERIVATIVES AND USES THEREOF

-

Paragraph 0390, (2013/03/26)

The present invention provides N6-substituted adenosine derivatives and N6-substituted adenine derivatives, manufacturing methods thereof, a pharmaceutical composition comprising the said compounds above, and uses of these compounds in manufacturing medicaments and health-care products for treating insomnia, convulsion, epilepsy, and Parkinson's diseases, and preventing and treating dementia.

N6-SUBSTITUTED ADENOSINE DERIVATIVES, N6-SUBSTITUTED ADENINE DERIVATIVES AND USES THEREOF

-

Page/Page column 92-93, (2012/11/06)

The present invention provides N6-substituted adenosine derivatives and N6-substituted adenine derivatives, manufacturing methods thereof, a pharmaceutical composition comprising the said compounds above, and uses of of these compounds in manufacturing medicaments and health-care products for treating insomnia, convulsion, epilepsy, and Parkinson's diseases, and preventing and treating dementia.

Synthesis of the azathiopurine analogs

Kowalska, Alicja,Pluta, Krystian

, p. 555 - 569 (2008/09/20)

The effective synthesis of the azathioprine analogs - 2-subsituted derivatives of 7-methyl-6-(1-methyl-4-nitroimidazol-5-ylthio)purines 5 has been achieved by the reaction of 2-subsituted 6-purinethiones 4 with 5-chloro-l-methyl-4-nitroimidazole in ethano

Imidazo[2,1-i]purin-5-ones and related tricyclic water-soluble purine derivatives: Potent A2A- and A3-adenosine receptor antagonistst

Müller, Christa E.,Thorand, Mark,Qurishi, Ramatullah,Diekmann, Martina,Jacobson, Kenneth A.,Padgett, William L.,Daly, John W.

, p. 3440 - 3450 (2007/10/03)

A series of tricyclic imidazo[2,1-i]purinones and ring-enlarged analogues derived from xanthine derivatives have been prepared as adenosine receptor (AR) antagonists. In comparison with xanthines, the tricyclic compounds exhibit increased water solubility due to a basic nitrogen atom, which can be protonated under physiological conditions. Substituents were introduced that confer high affinity for A2A or A3 ARs, respectively. A new capillary electrophoresis method was developed for the determination of the enantiomeric purity of selected chiral products using native and modified β-cyclodextrins as chiral discriminators. The compounds were investigated in radioligand binding assays at rat brain A1 and A2A ARs. Selected compounds were additionally investigated in radioligand binding assays at human recombinant A3 ARS and in functional studies (adenylate cyclase assays) at A1 ARs of rat fat cell membranes, A2A ARs of rat PC 12 cell membranes, and mouse A2B ARs of NIH 3T3 cell membranes. Structure-activity relationships were similar to those of corresponding xanthine derivatives. The 2-styrylimidazopurinones were less potent at A2A ARs as compared to 8-styrylxanthine derivatives. The most potent compound at A2A ARs was (S)-1,4-dimethyl-8-ethyl-2-styryl- imidazo[2,1-i]purinone (S-25) exhibiting a Ki value of 424 nM at rat A2A ARs. The compound was highly selective for A2A receptors vs A1 and A3 ARs. Selectivity vs A2B ARs, however, was low. Among the 1-unsubstituted 2-phenyl-imidazo[2,1-i]purin-5-one derivatives, very potent and highly selective antagonists for human A3 ARs were identified. The most potent A3 antagonist of the present series was (R)-4-methyl-8-ethyl-2-phenyl-imidazo[2,1-i]purin-5-one (R-24) exhibiting a Ki value of 2.3 nM and high selectivity for A3 receptors vs all other AR subtypes.

N-Methyl Nucleosidase from Tea Leaves

Negishi, Osamu,Ozawa, Tetsuo,Imagawa, Hiroshi

, p. 169 - 176 (2007/10/02)

N-Methyl nucleoside hydrolase (N-methyl nucleosidase, N-MeNase), which hydrolyzes 7-methylxanthosine to produce 7-methylxanthine, was detected in tea-leaf extracts and separated from adenosine nucleosidase (ANase, EC 3.2.2.7) by DEAE-cellulose column chromatography.The optimum pH for the N-MeNase ranged from 8.0 to 8.5.The enzyme was strongly inhibited by EDTA.Inhibition by the hydrolysis products of 7-methylxanthosine and 7-methylinosine was also observed.The molecular weight was estimated to be about 55000 by gel-filtration.Among purine and N-methylpurine nucleosides, 3- and 7-methylpurine nucleosides were hydrolyzed preferentially by N-MeNase.On the other hand, ANase could not hydrolyze 7-methylxanthosine, although the enzyme showed high activity toward 7-methyladenosine.As a result, it is suggested that N-MeNase catalyzes the hydrolysis reaction of 7-methylxanthosine in the pathway of caffeine biosynthesis, whereas ANase is not directly concerned with it.

2,6-Dialkoxy-7-methylpurines

Kowalska, Alicja,Maslankiewicz, Andrzej,Syrek, Barbara,Cieplinski, Piotr

, p. 341 - 352 (2007/10/02)

The preparation of unsymmetrical 2,6-dialkoxy-7-methylpurines (2), and 2-alkoxy-1,7-dialkyl-6-oxo-1,6-dihydropurines (5) is described.In contrast to 1 and 2, a facile thermal lactim-lactam rearrangement from hypoxanthines 5 and 7 into xanthines 6 was observed. - Keywords: Nucleophilic heteroaromatic substitution; thermal lactim-lactam rearrangement; Sigmatropic shifts; Dialkoxy-7H-purines; Dialkyl-1H(or 3H),7H-hypoxanthines; Trialkyl-7H-xanthines

ISOMERIZATION AND DEALKYLATION OF METHYLATED XANTHINIUM DERIVATIVES

Muravich-Aleksandr, Kh. L.,Kolesova, M. B.,Pernikova, V. G.,Smirnova, N. V.

, p. 562 - 567 (2007/10/02)

The isomerization or dealkylation of methylated xanthinium derivatives takes place with the participation of nucleophiles and is facilitated in the presence of a sterically hindered configuration.When heated, 7,9-dimethyl- and 1,7,9-trimethylxanthinium salts isomerize to theobromine and caffeine respectively.Under these conditions 3,7,9-trimethyl- and 1,3,7,9-tetramethylxanthinium salts are dealkylated.The 1,7,9- and 3,7,9-trimethylxanthinium betaines are isomerized quantitatively to caffeine.The role of the nucleophile under these conditions is played by the negatively charged fragment in the pyridine part of molecule.An intermolecular mechanism of rearrangement of the 3,7,9-trimethylxanthinium betaine is demonstrated.The sterically overloaded 1,3,8,9-tetramethylxanthine and 1,3,9-trimethyl-8-azaxanthine and not the charged compounds undergo rearrangement.In these cases the nucleophilic center is the doubly bonded N7 atom in the five-membered ring.

PHOTOCHEMISTRY OF PURINE 3-OXIDES IN HYDROXYLIC SOLVENTS

Lam, Fuk L.,Parham, James C.

, p. 2371 - 2376 (2007/10/02)

UV irradiation of the potent oncogen hypoxanthine 3-oxide in aqueoous solution induces elimination of and rearrangement of the nitrogen-bound oxygen.The extent of each reaction shows a complex variation over the pH range 0-7.The variations in quantum yield for product formation are shown to result from the presence in the neutral molecule of tautomeric species with differing photochemistries that ionize in the excited state (pKa* ca. 3.5) just above the protonation pKa (1.2).The photochemical reactivity of each ionic and each tautomeric form was assigned by comparing the effect of pH changes between 0 and 11 on the quantum yields for formation of each photoproduct from hypoxanthine 3-oxide with those of two model compounds, 1-hydroxyhypoxanthine and 6-methoxypurine 3-oxide.Photoreduction of the 3-oxides occurs via the triplet state.This process has a relatively consistent low quantum yield (Φ=0.005 to 0.04) for most ionic and tautomeric forms of both purine 1-oxides and purine 3-oxides.Photorearrangement is a much more efficient process for purine 3-oxides (Φ=0.3) than for purine 1-oxides (Φ=0.04).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 552-62-5